High expression level of CXCL1/GROα is linked to advanced stage and worse survival in uterine cervical cancer and facilitates tumor cell malignant processes

CXCL3 overexpression promotes the tumorigenic potential of uterine cervical cancer cells via the MAPK/ERK pathway

(2019) Ya‐Ling Qi et al.   JOURNAL OF CELLULAR PHYSIOLOGY

GRO-α and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1/NFκB signaling cascade

(2018) Mingo Ming-Ho Yung et al.   Theranostics

Cyclin D1 overexpression correlates with poor tumor differentiation and prognosis in gastric cancer

(2017) Yan-Shen Shan et al.   Oncology Letters

Epithelial-mesenchymal transition induced by GRO-α-CXCR2 promotes bladder cancer recurrence after intravesical chemotherapy

(2017) Lu Chen et al.   Oncotarget

Stromal cyclin D1 promotes heterotypic immune signaling and breast cancer growth

(2017) Timothy G. Pestell et al.   Oncotarget

Overexpression of CXCL3 can enhance the oncogenic potential of prostate cancer

(2016) Shi-liang Gui et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

CXCL1-Mediated Interaction of Cancer Cells with Tumor-Associated Macrophages and Cancer-Associated Fibroblasts Promotes Tumor Progression in Human Bladder Cancer

(2016) Makito Miyake et al.   NEOPLASIA

CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer

(2015) Zhe-Wei Wei et al.   CANCER LETTERS

Targeted silencing of CXCL1 by siRNA inhibits tumor growth and apoptosis in hepatocellular carcinoma

(2015) KE-QI HAN et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Prevalence and risk factors for cancer of the uterine cervix among women living in Kinshasa, the Democratic Republic of the Congo: a cross-sectional study

(2015) Catherine Ali-Risasi et al.   Infectious Agents and Cancer

Significance of apoptosis related proteins on malignant transformation of ovarian tumors: A comparison between Bcl-2/Bax ratio and p53 immunoreactivity

(2014) Tamer Zeren et al.   ACTA HISTOCHEMICA

Overexpression of Chemokine (C-X-C) ligand 1 (CXCL1) associated with tumor progression and poor prognosis in hepatocellular carcinoma

(2014) Zhongwei Cao et al.   Cancer Cell International

Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers

(2013) Makito Miyake et al.   BMC CANCER

Chemokine (C-X-C motif) ligand 1 (CXCL1) protein expression is increased in high-grade prostate cancer

(2013) Makito Miyake et al.   PATHOLOGY RESEARCH AND PRACTICE

A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis

(2012) Swarnali Acharyya et al.   CELL

Overexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer

(2011) W.-L. Cheng et al.   ANNALS OF ONCOLOGY

Induction of IGF-1R expression by EGR-1 facilitates the growth of prostate cancer cells

(2011) Yang Ma et al.   CANCER LETTERS

Mast cells have a protumorigenic role in human thyroid cancer

(2010) R M Melillo et al.   ONCOGENE

ELR+ CXC chemokines and oncogenic Ras-mediated tumorigenesis

(2009) Kevin M. O'Hayer et al.   CARCINOGENESIS

Prevalence of micronuclei in exfoliated uterine cervical cells from patients with risk factors for cervical cancer

(2009) Lízia Maria Franco dos Reis Campos et al.   Sao Paulo Medical Journal

Heregulin β1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1

(2008) Chengfeng Yang et al.   BIOCHEMICAL JOURNAL

NF-kappa B genes have a major role in Inflammatory Breast Cancer

(2008) Florence Lerebours et al.   BMC CANCER

Secreted CXCL1 Is a Potential Mediator and Marker of the Tumor Invasion of Bladder Cancer

(2008) H. Kawanishi et al.   CLINICAL CANCER RESEARCH

IL–1β-stimulated activation of ERK1/2 and p38α MAPK mediates the transcriptional up-regulation of IL–6, IL–8 and GRO-α in HeLa cells

(2007) Huei-Ting Yang et al.   CELLULAR SIGNALLING